Exposure-Based Treatment for Perfectionism

Sponsor
Florida State University (Other)
Overall Status
Completed
CT.gov ID
NCT04500457
Collaborator
(none)
74
1
2
16.8
4.4

Study Details

Study Description

Brief Summary

This study is examining the efficacy of a computerized, exposure-based, intervention for perfectionism.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Exposure-based Treatment for Perfectionism (ETP)
N/A

Detailed Description

The primary aim of this study is to evaluate the effects of a two-week computerized exposure-based treatment for perfectionism (ETP). Individuals with elevated perfectionism will be randomly assigned to ETP or a waitlist (WL) control condition. ETP will consist of three tasks in which they will repeatedly make mistakes, repeated for five sessions over a two-week period (one session every 3 days).

Study Design

Study Type:
Interventional
Actual Enrollment :
74 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Preliminary Evaluation of an Exposure-Based Treatment for Perfectionism
Actual Study Start Date :
Oct 3, 2019
Actual Primary Completion Date :
Feb 26, 2021
Actual Study Completion Date :
Feb 26, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

This arm consists of a 2-week computerized, exposure-based intervention. Treatment sessions are completed every 3 days at home (5 treatment sessions total).

Behavioral: Exposure-based Treatment for Perfectionism (ETP)
Three tasks focused on exposures are completed. Each treatment session is approximately twenty minutes.

No Intervention: Wait-List Control

Participants in this condition will not receive treatment.

Outcome Measures

Primary Outcome Measures

  1. Frost Multidimensional Perfectionism Scale (FMPS)- Concern Over Mistakes Subscale [Change in levels of perfectionism from baseline to post treatment (2 weeks)]

    Self-report questionnaire examining levels of perfectionism. The concern over mistakes sub-scale includes 9 items with scores ranging from 9 to 45 (higher scores signify higher levels of perfectionism).

Secondary Outcome Measures

  1. Center for Epidemiological Studies Depression Scale (CES-D) [Change in depression symptoms from baseline to post treatment (2 weeks)]

    Self-report measure used to assess depressive symptoms. Total scores range from 0 to 60 with higher scores indicating a higher level of depressive symptoms.

  2. State-Trait Inventory for Cognitive and Somatic Anxiety-Trait Version (STICSA-T) [Change in overall anxiety symptoms from baseline to post treatment (2 weeks)]

    Self-report measure used to assess overall anxiety symptoms. Scores range from 21 to 84 with higher scores indicating higher levels of overall anxiety.

  3. Social Phobia inventory (SPIN) [Change in social anxiety symptoms from baseline to post treatment (2 weeks)]

    Self-report scale that measures Social anxiety symptoms. Scores range from 0 to 68 with higher scores indicating higher levels of social anxiety symptoms.

  4. Eating Attitudes Test (EAT-26) [Change in eating disorder symptoms from baseline to post treatment (2 weeks)]

    Self-report scale that measures eating disorder symptoms. Scores range from 0 to 78 with higher scores indicating higher levels of eating disorder symptoms.

  5. Obsessive-Compulsive Inventory- Revised (OCI-R) [Change in obsessive-compulsiveness from baseline to post treatment (2 weeks)]

    Self-report scale that measures obsessive-compulsiveness. Scores range from 0 to 72 with higher scores indicating higher levels of obsessive-compulsiveness.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Score of at least 29 on the Frost Multidimensional Perfectionism Scale- Concern over Mistakes subscale
Exclusion Criteria:
  • Current moderate or severe substance use disorder, psychotic disorder, or bipolar disorder

  • Current suicidal ideation (imminent risk)

  • Currently participating in psychotherapy

  • Any changes to psychotropic medications in the past four weeks

Contacts and Locations

Locations

Site City State Country Postal Code
1 Florida State University, Department of Psychology Tallahassee Florida United States 32306

Sponsors and Collaborators

  • Florida State University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jesse Cougle, Associate Professor of Psychology, Florida State University
ClinicalTrials.gov Identifier:
NCT04500457
Other Study ID Numbers:
  • HSC2019.27351
First Posted:
Aug 5, 2020
Last Update Posted:
May 18, 2021
Last Verified:
May 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of May 18, 2021